Advertisement

Topics

Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

20:00 EDT 9 May 2019 | Globe Newswire

CRANBURY, N.J., May 10, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas, NV on Tuesday, May 14, 2019 at 1:00 p.m. PT.

A live audio webcast of the presentation can also be accessed via the Investors section of the Amicus Therapeutics corporate website at http://ir.amicusrx.com/events-and-presentations, and will be archived for 90 days.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

CONTACTS:

Investors/Media:
Amicus Therapeutics
Sara Pellegrino, IRC
Vice President, Investor Relations & Corporate Communications
IR@amicusrx.com
(609) 662-5044

Media:
Amicus Therapeutics
Marco Winkler
mwinkler@amicusrx.com
(609) 662-2798

FOLD–G

Amicus-logo.jpg

NEXT ARTICLE

More From BioPortfolio on "Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...